No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents, Immunological / administration & dosage
-
Antineoplastic Agents, Immunological / adverse effects
-
Antineoplastic Agents, Immunological / therapeutic use*
-
B-Cell Maturation Antigen / antagonists & inhibitors*
-
Drug Resistance, Neoplasm
-
Humans
-
Immunoconjugates / administration & dosage
-
Immunoconjugates / adverse effects
-
Immunoconjugates / therapeutic use*
-
Multiple Myeloma / diagnosis
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / etiology
-
Multiple Myeloma / mortality
-
Recurrence
-
Retreatment
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Immunological
-
B-Cell Maturation Antigen
-
Immunoconjugates
-
TNFRSF17 protein, human